S. Šemrl

Neutralizing effects of anti-infliximab antibodies on synergistically-stimulated human coronary artery endothelial cells.

S. Čučnik, S. Praprotnik, P. Žigon, 2019, Atherosclerosis.

Detection of Antiphosphatidylserine/Prothrombin Antibodies and Their Potential Diagnostic Value

S. Čučnik, T. Kveder, B. Božič, 2013, Clinical & developmental immunology.

Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis

M. Tomšič, M. Hawlina, A. Hočevar, 2016, Medicine.

Early giant cell arteritis: Identifying duration from symptoms to diagnosis, possible therapies and clinically-relevant cell dynamics

S. Čučnik, M. Tomšič, A. Hočevar, 2018 .

Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements

S. Čučnik, M. Tomšič, S. Praprotnik, 2018, Clinical Rheumatology.

Laboratory Methodology Important in the Diagnosis and Prognosis of Antiphospholipid Syndrome

S. Čučnik, T. Kveder, B. Božič, 2015 .

Stroke and antiphospholipid syndrome—antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event

S. Čučnik, M. Zaletel, M. Tomšič, 2018, Clinical Rheumatology.